BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21423204)

  • 1. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
    Mullany LK; Fan HY; Liu Z; White LD; Marshall A; Gunaratne P; Anderson ML; Creighton CJ; Xin L; Deavers M; Wong KK; Richards JS
    Oncogene; 2011 Aug; 30(32):3522-36. PubMed ID: 21423204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.
    Mullany LK; Liu Z; King ER; Wong KK; Richards JS
    Endocrinology; 2012 Apr; 153(4):1638-48. PubMed ID: 22396451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cells.
    Fan HY; Liu Z; Paquet M; Wang J; Lydon JP; DeMayo FJ; Richards JS
    Cancer Res; 2009 Aug; 69(16):6463-72. PubMed ID: 19679546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
    Lawrenson K; Sproul D; Grun B; Notaridou M; Benjamin E; Jacobs IJ; Dafou D; Sims AH; Gayther SA
    Carcinogenesis; 2011 Oct; 32(10):1540-9. PubMed ID: 21859834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of miR-34c as a putative tumor suppressor in high-grade serous ovarian cancer.
    Yu Z; Kim J; He L; Creighton CJ; Gunaratne PH; Hawkins SM; Matzuk MM
    Biol Reprod; 2014 Nov; 91(5):113. PubMed ID: 25273528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
    Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
    Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis.
    Shi M; Whorton AE; Sekulovski N; Paquet M; MacLean JA; Song Y; Van Dyke T; Hayashi K
    Biol Reprod; 2020 Apr; 102(5):1055-1064. PubMed ID: 31930396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
    Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
    Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.
    Wu R; Zhai Y; Kuick R; Karnezis AN; Garcia P; Naseem A; Hu TC; Fearon ER; Cho KR
    J Pathol; 2016 Nov; 240(3):341-351. PubMed ID: 27538791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
    Zhang L; Ma T; Brozick J; Babalola K; Budiu R; Tseng G; Vlad AM
    Oncogene; 2016 Sep; 35(38):5010-20. PubMed ID: 26973247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells.
    Fadiel A; Chen Z; Ulukus E; Ohtani K; Hatami M; Naftolin F
    Reprod Sci; 2012 Aug; 19(8):797-805. PubMed ID: 22477337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
    Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
    Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.
    Wu J; Liu Z; Shao C; Gong Y; Hernando E; Lee P; Narita M; Muller W; Liu J; Wei JJ
    Cancer Res; 2011 Jan; 71(2):349-59. PubMed ID: 21224353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
    Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J
    BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression.
    Tanwar PS; Kaneko-Tarui T; Lee HJ; Zhang L; Teixeira JM
    Carcinogenesis; 2013 Apr; 34(4):893-901. PubMed ID: 23276799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.
    Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A
    Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 19. The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice.
    Kim J; Coffey DM; Ma L; Matzuk MM
    Endocrinology; 2015 Jun; 156(6):1975-81. PubMed ID: 25815421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.